All Stories

  1. Tocilizumab for the treatment of adult-onset Still’s disease
  2. The role of biologics in the treatment of giant cell arteritis
  3. Anakinra for the treatment of adult-onset Still’s disease
  4. Inflammatory Arthritis and Heart Disease
  5. Relative Risk Chart Score for the Assessment of the Cardiovascular Risk in Young Patients with Ankylosing Spondylitis
  6. Significant sE-Selectin levels reduction after 6 months of anti-TNF-α therapy in non-diabetic patients with moderate-to-severe psoriasis
  7. Efficacy of Anakinra in Refractory Adult-Onset Stillʼs Disease
  8. Relationship of Leptin with adiposity and inflammation and Resistin with disease severity in Psoriatic patients undergoing anti-TNF-alpha therapy
  9. No evidence of association between functional polymorphisms located within IL6R and IL6ST genes and Henoch–Schönlein purpura
  10. The Potential Effect of TNF-α Antagonist Therapy in Rheumatoid Arthritis may Depend on the Degree and Severity of Insulin Resistance Before the Onset of this Therapy